182 related articles for article (PubMed ID: 28240178)
61. Pectin-capped gold nanoparticles synthesis in-situ for producing durable, cytocompatible, and superabsorbent hydrogel composites with chitosan.
de Almeida DA; Sabino RM; Souza PR; Bonafé EG; Venter SAS; Popat KC; Martins AF; Monteiro JP
Int J Biol Macromol; 2020 Mar; 147():138-149. PubMed ID: 31923518
[TBL] [Abstract][Full Text] [Related]
62. Characterization of novel lactoferrin loaded capsules prepared with polyelectrolyte complexes.
Wu QX; Zhang QL; Lin DQ; Yao SJ
Int J Pharm; 2013 Oct; 455(1-2):124-31. PubMed ID: 23891653
[TBL] [Abstract][Full Text] [Related]
63. Aceclofenac delivery by microencapsulation using LBL self-assembly for delayed release.
Dharmendra K; Manisha P; Kymonil KM; Awasthi SS
Pak J Pharm Sci; 2011 Oct; 24(4):495-502. PubMed ID: 21959811
[TBL] [Abstract][Full Text] [Related]
64. Fabrication of a novel pH-sensitive glutaraldehyde cross-linked pectin nanogel for drug delivery.
Chang C; Wang ZC; Quan CY; Cheng H; Cheng SX; Zhang XZ; Zhuo RX
J Biomater Sci Polym Ed; 2007; 18(12):1591-9. PubMed ID: 17988522
[TBL] [Abstract][Full Text] [Related]
65. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
66. Enhancement of site specific delivery of diloxanide furoate as an antiamoebic drug.
Tiwari V; Verma S; Verma SK; Dangi JS
Eur J Pharm Sci; 2016 Apr; 86():50-7. PubMed ID: 26952868
[TBL] [Abstract][Full Text] [Related]
67. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release.
Das S; Chaudhury A; Ng KY
Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477
[TBL] [Abstract][Full Text] [Related]
68. Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer.
Dinarvand M; Kiani M; Mirzazadeh F; Esmaeili A; Mirzaie Z; Soleimani M; Dinarvand R; Atyabi F
Int J Biol Macromol; 2015; 78():112-21. PubMed ID: 25858880
[TBL] [Abstract][Full Text] [Related]
69. Immersion coating of pellet cores consisting of chitosan and calcium intended for colon drug delivery.
Hiorth M; Skøien T; Sande SA
Eur J Pharm Biopharm; 2010 Jun; 75(2):245-53. PubMed ID: 20188827
[TBL] [Abstract][Full Text] [Related]
70. Investigating the potential of Tamarindus indica pectin-chitosan conjugate for reducing recovery period in TNBS induced colitis.
Sethi S; Khurana RK; Kamboj S; Sharma R; Singh A; Rana V
Int J Biol Macromol; 2017 May; 98():739-747. PubMed ID: 28167113
[TBL] [Abstract][Full Text] [Related]
71. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
72. Simple nanophotosensitizer fabrication using water-soluble chitosan for photodynamic therapy in gastrointestinal cancer cells.
Jeong YI; Cha B; Lee HL; Song YH; Jung YH; Kwak TW; Choi C; Jeong GW; Nah JW; Kang DH
Int J Pharm; 2017 Oct; 532(1):194-203. PubMed ID: 28888976
[TBL] [Abstract][Full Text] [Related]
73. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
Badran MM; Mady MM; Ghannam MM; Shakeel F
Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
[TBL] [Abstract][Full Text] [Related]
74. Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol.
Prezotti FG; Boni FI; Ferreira NN; Silva DS; Almeida A; Vasconcelos T; Sarmento B; Gremião MPD; Cury BSF
Drug Dev Ind Pharm; 2020 Feb; 46(2):236-245. PubMed ID: 31928345
[TBL] [Abstract][Full Text] [Related]
75. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
[TBL] [Abstract][Full Text] [Related]
76. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.
Macleod GS; Fell JT; Collett JH; Sharma HL; Smith AM
Int J Pharm; 1999 Oct; 187(2):251-7. PubMed ID: 10502631
[TBL] [Abstract][Full Text] [Related]
77. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
[TBL] [Abstract][Full Text] [Related]
78. Preparation of core-shell hordein/pectin nanoparticles as quercetin delivery matrices: Physicochemical properties and colon-specific release analyses.
Zhang X; Wei Z; Sun Y; Luo T; Xue C
Food Res Int; 2023 Aug; 170():112971. PubMed ID: 37316013
[TBL] [Abstract][Full Text] [Related]
79. Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery.
Maestrelli F; Cirri M; Mennini N; Bragagni M; Zerrouk N; Mura P
Drug Dev Ind Pharm; 2012 Sep; 38(9):1142-51. PubMed ID: 22191551
[TBL] [Abstract][Full Text] [Related]
80. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
